The Academy has updated its policy statement on influenza to include a new antiviral
The policy Recommendations for Prevention and Control of Influenza in Children, 2017-2018, now provides dosage and administration information for intravenous peramivir, a
The drug was approved in September for use as treatment for acute uncomplicated influenza
in non-hospitalized children 2 years and older. Peramivir is one of three available
antivirals for influenza along with oseltamivir and zanamivir, which also are detailed
in the policy.